NASDAQ:MYGN

Myriad Genetics Earnings Date, Estimates & History

$27.84

-0.59 (-2.08 %)

(As of 03/5/2021 12:00 AM ET)

Add

Compare

Today's Range

$26.76

Now: $27.84▼

$28.63

50-Day Range

$25.80

MA: $28.75▼

$31.34

52-Week Range

$9.24

Now: $27.84▼

$31.60

Volume569,236 shs

Average Volume893,033 shs

Market Capitalization$2.09 billion

P/E RatioN/A

Dividend YieldN/A

Beta1.71

Myriad Genetics (NASDAQ:MYGN) Earnings Information

Myriad Genetics last posted its earnings data on February 22nd, 2021. The reported ($0.12) earnings per share for the quarter, hitting the consensus estimate of ($0.12). The business earned $154.60 million during the quarter, compared to analysts' expectations of $148.11 million. Its revenue for the quarter was down 20.8% compared to the same quarter last year. Myriad Genetics has generated ($0.35) earnings per share over the last year. Myriad Genetics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 4th, 2021 based off prior year's report dates.

Myriad Genetics Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Myriad Genetics (NASDAQ:MYGN) Earnings Estimates

2021 EPS Consensus Estimate: ($0.12)

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2021	2	$0.01	$0.09	$0.05
Q2 2021	3	($0.24)	$0.19	($0.08)
Q3 2021	3	($0.23)	$0.08	($0.07)
Q4 2021	3	($0.07)	$0.01	($0.02)

Myriad Genetics (NASDAQ MYGN) Earnings History by Quarter

Date	Quarter	Consensus Estimate	Reported EPS	GAAP EPS	Revenue Estimate	Actual Revenue	Conference Call
5/4/2021 (Estimated)
2/22/2021	Q1 21	($0.12)	($0.12)	$0.21	$148.11 million	$154.60 million	Transcript
11/9/2020	9/30/2020	($0.30)	($0.15)	($0.18)	$134.59 million	$145.20 million	Transcript
8/13/2020	6/30/2020	($0.47)	($0.31)	$0.08	$95.44 million	$93.20 million	Transcript
5/5/2020	3/31/2020	$0.02	($0.08)	$1.23	$167.38 million	$164.00 million	Transcript
2/6/2020	Q2 2020	$0.22	$0.23	$0.41	$209.61 million	$195.10 million	Transcript
11/4/2019	Q1	$0.26	$0.08	$0.22	$202.34 million	$186.30 million	Transcript
8/13/2019	Q4 19	$0.40	$0.41	$0.66	$221.64 million	$215.40 million	Transcript
5/7/2019	3/31/2019	$0.38	$0.34	$0.59	$217.76 million	$216.60 million	N/A
2/5/2019	12/31/2018	$0.34	$0.38	$0.57	$217.69 million	$216.80 million	Listen
11/6/2018	9/30/2018	$0.30	$0.43	$0.71	$203.20 million	$202.30 million	Listen

8/21/2018	6/30/2018	$0.33	$0.38	$0.58	$195.93 million	$200.90 million	N/A
5/8/2018	Q3	$0.27	$0.31	$0.46	$188.22 million	$193.50 million	N/A
2/6/2018	Q2 2018	$0.2360	$0.31	$0.17	$188.72 million	$194.00 million	Transcript
11/7/2017	Q1 2018	$0.21	$0.26	($0.63)	$183.52 million	$190.20 million	N/A
8/8/2017	Q4 17	$0.26	$0.30	$0.41	$193.71 million	$200.50 million	Listen
5/2/2017	Q3 2017	$0.2380	$0.27	$0.48	$188.89 million	$196.90 million	Listen
2/7/2017	Q2 2017	$0.24	$0.26	$0.43	$189.72 million	$196.50 million	Listen
11/1/2016	Q117	$0.26	$0.23	$0.48	$172.31 million	$177.50 million	N/A
8/9/2016	Q416	$0.38	$0.36	$0.40	$187.95 million	$186.50 million	N/A
5/3/2016	Q316	$0.38	$0.41	$0.38	$185.08 million	$190.50 million	N/A
2/2/2016	Q216	$0.41	$0.45	$0.49	$189.99 million	$193.30 million	N/A
11/3/2015	Q116	$0.35	$0.41	$0.45	$177.89 million	$183.50 million	N/A
8/11/2015	Q415	$0.42	$0.41	$0.56	$187.81 million	$189.90 million	Listen
5/5/2015	Q315	$0.39	$0.40	$0.51	$183.30 million	$180.00 million	Listen
2/3/2015	Q215	$0.35	$0.40	$0.48	$183.41 million	$184.40 million	Listen
11/4/2014	Q115	$0.33	$0.25	$0.29	$175.00 million	$168.84 million	Listen
8/12/2014	Q414	$0.46	$0.48	$0.53	$187.68 million	$188.80 million	Listen
5/6/2014	Q314	$0.45	$0.60	$0.72	$175.23 million	$182.92 million	Listen
2/4/2014	Q2 2014	$0.47	$0.66	$0.66	$176.02 million	$204.06 million	Listen
11/5/2013	Q1 2014	$0.46	$0.68	$0.68	$167.64 million	$202.50 million	Transcript
8/13/2013	Q4 2013	$0.44	$0.53	$0.53	$159.87 million	$174.10 million	Transcript
5/7/2013	Q3 2013	$0.39	$0.46	$0.46	$148.25 million	$156.40 million	N/A
2/5/2013	Q2 2013	$0.38	$0.42		$143.71 million	$140.70 million	Listen
11/5/2012	Q113	$0.32	$0.36		$129.84 million	$133.40 million	N/A
8/14/2012		$0.34	$0.34				Transcript
5/1/2012		$0.32	$0.34				Transcript
1/31/2012		$0.31	$0.33				N/A
11/1/2011		$0.27	$0.29				N/A
8/9/2011		$0.29	$0.30				Transcript
5/3/2011		$0.25	$0.31				N/A
1/27/2011		$0.26	$0.26				N/A
11/2/2010	Q1 2011	$0.23	$0.24	$0.24			N/A
8/10/2010	Q4 2010	$0.33	$0.39	$0.24			N/A
5/4/2010	Q3 2010	$0.38	$0.33	$0.33			N/A
2/2/2010	Q2 2010	$0.34	$0.36	$0.36			N/A
11/3/2009	Q1 2010	$0.32	$0.31	$0.31			N/A
8/25/2009	Q4 2009	$0.23	$0.37	$0.50			N/A
5/4/2009	Q3 2009	$0.23	$0.25	$0.25			N/A
2/3/2009	Q2 2009	$0.17	$0.22	$0.22			N/A
11/4/2008	Q1 2009	$0.07	$0.15	$0.15			N/A
8/19/2008	Q4 2008	($0.12)	$0.70	$0.70			N/A
5/6/2008	Q3 2008	($0.05)	($0.05)	($0.05)			N/A
2/5/2008	Q2 2008	($0.08)	($0.06)	($0.06)			N/A

(Earnings results data provided by Zacks Investment Research)

This page was last updated on 3/6/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Myriad Genetics Earnings Date, Estimates & History

Adding

Adding

Adding Myriad Genetics, Inc.

Earnings

Myriad Genetics (NASDAQ:MYGN) Earnings Information

Myriad Genetics Earnings Estimates and Actuals by Quarter

Myriad Genetics (NASDAQ:MYGN) Earnings Estimates

Myriad Genetics (NASDAQ MYGN) Earnings History by Quarter

30 Days of MarketBeat All Access for $1.00

Premium Research Tools

Market Data and Calendars

Investing Education and Resources